Abiomed Inc (ABMD)

108.87
NASDAQ : Health Care
Prev Close 107.39
Day Low/High 106.80 / 109.83
52 Wk Low/High 67.81 / 132.95
Avg Volume 549.50K
Exchange NASDAQ
Shares Outstanding 43.38M
Market Cap 4.66B
EPS 0.90
P/E Ratio 110.71
Div & Yield N.A. (N.A)

Latest News

Abiomed Receives FDA IDE Approval For Initiation Of Door To Unloading (DTU) Prospective Feasibility Study

Abiomed Receives FDA IDE Approval For Initiation Of Door To Unloading (DTU) Prospective Feasibility Study

Study Evaluates the Safety and Feasibility of Unloading of the Left Ventricle with Impella CP® in STEMI Patients, without Cardiogenic Shock

Abiomed's Impella Technology Showcased At TCT 2016 With More Than 25 Presentations During Scientific Sessions

Abiomed's Impella Technology Showcased At TCT 2016 With More Than 25 Presentations During Scientific Sessions

Abiomed is Committed to Improving Outcomes in Protected PCI and Cardiogenic Shock

Abiomed (ABMD) Hits New Lifetime High

Abiomed (ABMD) Hits New Lifetime High

Trade-Ideas LLC identified Abiomed (ABMD) as a new lifetime high candidate

Abiomed Announces Q1 FY 2017 Revenue Of $103.0 Million, Up 40% Over Prior Year

Abiomed Announces Q1 FY 2017 Revenue Of $103.0 Million, Up 40% Over Prior Year

Lower end of revenue guidance increased for FY 2017

'Mad Money' Lightning Round: Take Bristol-Myers Over Juno

'Mad Money' Lightning Round: Take Bristol-Myers Over Juno

Cramer says Abiomed is too expensive while Harman was hurt by the strong dollar.

Jim Cramer's 'Mad Money' Recap: Why Some Stocks Pass Earnings Test and Others Fail

Jim Cramer's 'Mad Money' Recap: Why Some Stocks Pass Earnings Test and Others Fail

Johnson & Johnson was easy, Cramer says, but other stocks were more problematic.

ABIOMED Stock Sees Short Interest Fall 12.5%

ABIOMED Stock Sees Short Interest Fall 12.5%

The most recent short interest data has been released for the 06/30/2016 settlement date, which shows a 365,960 share decrease in total short interest for ABIOMED, Inc. , to 2,561,708, a decrease of 12.50% since 06/15/2016.

Abiomed (ABMD) Hits New Lifetime High

Abiomed (ABMD) Hits New Lifetime High

Trade-Ideas LLC identified Abiomed (ABMD) as a new lifetime high candidate

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of Abiomed

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of Abiomed

Levi & Korsinsky announces it has commenced an investigation of Abiomed (NASDAQ: ABMD) concerning possible breaches of fiduciary duty by the board of directors of the company.

Insider Trading Alert - ABMD, POWI And AOS Traded By Insiders

Insider Trading Alert - ABMD, POWI And AOS Traded By Insiders

Stocks with insider trader activity include ABMD, POWI and AOS

2 Momentum Health Care Stocks That Will Continue to Outpace the Industry

2 Momentum Health Care Stocks That Will Continue to Outpace the Industry

If you're looking for high-velocity stocks in a low-velocity broader market, consider these little-known but fast-rising health care stars.

Abiomed Announces Q4 FY 2016 Revenue Of $94.0 Million, Up 39% Over Prior Year

Abiomed Announces Q4 FY 2016 Revenue Of $94.0 Million, Up 39% Over Prior Year

- Total Year Revenue of $329.5 Million, Up 43% Over Prior Year

Trade-Ideas: Abiomed (ABMD) Is Today's Post-Market Leader Stock

Trade-Ideas: Abiomed (ABMD) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Abiomed (ABMD) as a post-market leader candidate

Abiomed Impella® Therapy Receives FDA Approval For Cardiogenic Shock After Heart Attack Or Heart Surgery

Abiomed Impella® Therapy Receives FDA Approval For Cardiogenic Shock After Heart Attack Or Heart Surgery

Entire Family of Impella Left Side Heart Pumps FDA Approved To Enable Heart Recovery

Insider Trading Alert - PLUG, RP And ABMD Traded By Insiders

Insider Trading Alert - PLUG, RP And ABMD Traded By Insiders

Stocks with insider trader activity include PLUG, RP and ABMD

Abiomed (ABMD) Stock: Weak On High Volume Today

Abiomed (ABMD) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Abiomed (ABMD) as a weak on high relative volume candidate

Abiomed (ABMD) Is Water-Logged And Getting Wetter Today

Abiomed (ABMD) Is Water-Logged And Getting Wetter Today

Trade-Ideas LLC identified Abiomed (ABMD) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Today Was the Inverse of Last Year

The haves didn't have it, but there's underlying strength.